Repligen (RGEN) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.66% |
| Dec 31, 2025 | -28.09% |
| Sep 30, 2025 | 26.20% |
| Jun 30, 2025 | 6.75% |
| Mar 31, 2025 | 21.21% |
| Dec 31, 2024 | 13.76% |
| Sep 30, 2024 | 15.48% |
| Jun 30, 2024 | 11.86% |
| Mar 31, 2024 | 42.14% |
| Dec 31, 2023 | -19.24% |
| Sep 30, 2023 | 18.19% |
| Jun 30, 2023 | 60.64% |
| Mar 31, 2023 | 318.17% |
| Dec 31, 2022 | -28.59% |
| Sep 30, 2022 | 104.05% |
| Jun 30, 2022 | -43.42% |
| Mar 31, 2022 | 172.85% |
| Dec 31, 2021 | -72.59% |
| Sep 30, 2021 | 54.14% |
| Jun 30, 2021 | 35.03% |
| Mar 31, 2021 | 19.09% |
| Dec 31, 2020 | 51.32% |
| Sep 30, 2020 | 23.08% |
| Jun 30, 2020 | 14.31% |
| Mar 31, 2020 | 28.55% |
| Dec 31, 2019 | 85.47% |
| Sep 30, 2019 | 35.06% |
| Jun 30, 2019 | 57.83% |
| Mar 31, 2019 | 0.79% |
| Dec 31, 2018 | 12.05% |
| Sep 30, 2018 | 33.75% |
| Jun 30, 2018 | -17.22% |
| Mar 31, 2018 | -69.96% |
| Dec 31, 2017 | 14.65% |
| Sep 30, 2017 | -26.72% |
| Sep 30, 2016 | -14.27% |
| Jun 30, 2016 | 39.75% |
| Mar 31, 2016 | -40.26% |
| Dec 31, 2015 | 23.93% |
| Sep 30, 2015 | 43.12% |
| Jun 30, 2015 | 72.41% |